Lupin Deal Spree Continues, Looks ‘Down Under’ For Generic Growth
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Three weeks after it announced the acquisition of German generic firm Hormosan, the world's largest manufacturer of anti-TB drugs - Lupin - has bought a minority stake in Australian drug maker Generic Health (PharmAsia News, July 31, 2008)
You may also be interested in...
Lupin Buys Stake In South Africa’s Pharma Dynamics; Aims To Be In Top 3
MUMBAI - After months of negotiations, Indian generic drug maker Lupin acquired a 60 percent equity stake in South Africa's sixth largest generic drug maker Pharma Dynamics with the goal of joining the top ranks of companies in South Africa in three years
Lupin Buys Stake In South Africa’s Pharma Dynamics; Aims To Be In Top 3
MUMBAI - After months of negotiations, Indian generic drug maker Lupin acquired a 60 percent equity stake in South Africa's sixth largest generic drug maker Pharma Dynamics with the goal of joining the top ranks of companies in South Africa in three years
GSK Takes Lupin To Court To Block Generic Combivir Launch in the U.S.
MUMBAI - Europe's largest drugmaker GlaxoSmithKline has sued Indian drug maker Lupin for infringement of its patents for anti-AIDS drug Combivir in the U.S